Stockreport

Two Smaller Companies Worthy of Your "Attention" [Yahoo! Finance]

Precipio, Inc.  (PRPO) 
US:NASDAQ Investor Relations: precipiodx.com/investors.html
PDF Elite Pharmaceuticals Inc. recently received FDA approval for its generic version of Vyanse and expects to launch the product in early 2025. Image Source: Zacks Invest [Read more]